CyDex names new president and COO

Dr Odlaug served as executive vice president and a member of the senior management committee at Fujisawa Healthcare until its merger with Yamanouchi in 2005, which resulted in the formation of Astellas Pharma. He left Astellas in 2006 after successfully completing the post-merger integration process, and most recently was the managing partner of EIR Healthcare Advisors.

While at Fujisawa, Dr Odlaug was responsible for manufacturing, regulatory and quality assurance, technical services, commercial compliance, human resources, legal, information technology, corporate communications and strategic relations.

Mr Odlaug holds Bachelor’s and Master’s degrees from the University of Missouri at Kansas City and a PhD in public health from the University of Minnesota.

John Siebert, chairman and CEO of CyDex, said: “Ted’s experience in leading and growing pharmaceutical organizations will add significant value to CyDex and our management team.”